Duncker Streett & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $598K | Buy |
24,821
+280
| +1% | +$7.32K | 0.1% | 151 |
|
|
2026
Q1 | $689K | Sell |
24,541
-300
| -1% | -$7.99K | 0.13% | 136 |
|
|
2025
Q4 | $619K | Sell |
24,841
-498
| -2% | -$12.6K | 0.11% | 132 |
|
|
2025
Q3 | $646K | Buy |
25,339
+300
| +1% | +$7.41K | 0.11% | 128 |
|
|
2025
Q2 | $607K | Sell |
25,039
-1,722
| -6% | -$40.2K | 0.11% | 136 |
|
|
2025
Q1 | $678K | Sell |
26,761
-1,440
| -5% | -$37.7K | 0.13% | 127 |
|
|
2024
Q4 | $748K | Sell |
28,201
-10,159
| -26% | -$276K | 0.14% | 117 |
|
|
2024
Q3 | $1.11M | Sell |
38,360
-3,763
| -9% | -$110K | 0.2% | 103 |
|
|
2024
Q2 | $1.18M | Sell |
42,123
-5,008
| -11% | -$138K | 0.23% | 97 |
|
|
2024
Q1 | $1.31M | Sell |
47,131
-3,656
| -7% | -$101K | 0.26% | 91 |
|
|
2023
Q4 | $1.46M | Sell |
50,787
-2,805
| -5% | -$84.8K | 0.31% | 83 |
|
|
2023
Q3 | $1.78M | Sell |
53,592
-2,592
| -5% | -$91.7K | 0.41% | 68 |
|
|
2023
Q2 | $2.06M | Sell |
56,184
-120
| -0.2% | -$4.67K | 0.46% | 65 |
|
|
2023
Q1 | $2.3M | Sell |
56,304
-3,615
| -6% | -$156K | 0.55% | 56 |
|
|
2022
Q4 | $3.07M | Buy |
59,919
+17
| +0% | +$815 | 0.74% | 46 |
|
|
2022
Q3 | $2.62M | Sell |
59,902
-1,039
| -2% | -$50.5K | 0.68% | 47 |
|
|
2022
Q2 | $3.19M | Buy |
60,941
+19
| +0% | +$968 | 0.77% | 41 |
|
|
2022
Q1 | $3.15M | Sell |
60,922
-4,774
| -7% | -$248K | 0.63% | 46 |
|
|
2021
Q4 | $3.88M | Buy |
65,696
+1,117
| +2% | +$55.3K | 0.67% | 43 |
|
|
2021
Q3 | $2.78M | Buy |
64,579
+3,203
| +5% | +$142K | 0.53% | 63 |
|
|
2021
Q2 | $2.4M | Sell |
61,376
-1,204
| -2% | -$46.8K | 0.44% | 77 |
|
|
2021
Q1 | $2.27M | Sell |
62,580
-9,520
| -13% | -$338K | 0.43% | 79 |
|
|
2020
Q4 | $2.65M | Sell |
72,100
-5,581
| -7% | -$205K | 0.51% | 62 |
|
|
2020
Q3 | $2.71M | Buy |
77,681
+136
| +0.2% | +$4.77K | 0.59% | 54 |
|
|
2020
Q2 | $2.41M | Sell |
77,545
-10,320
| -12% | -$351K | 0.57% | 59 |
|
|
2020
Q1 | $2.72M | Sell |
87,865
-689
| -0.8% | -$23.5K | 0.73% | 45 |
|
|
2019
Q4 | $3.29M | Sell |
88,554
-356
| -0.4% | -$12.7K | 0.69% | 49 |
|
|
2019
Q3 | $3.03M | Buy |
88,910
+822
| +0.9% | +$29.9K | 0.7% | 45 |
|
|
2019
Q2 | $3.62M | Sell |
88,088
-4,124
| -4% | -$164K | 0.81% | 31 |
|
|
2019
Q1 | $3.72M | Buy |
92,212
+35
| +0% | +$1.4K | 0.86% | 28 |
|
|
2018
Q4 | $3.82M | Sell |
92,177
-407
| -0.4% | -$16.9K | 1.02% | 17 |
|
|
2018
Q3 | $3.87M | Buy |
92,584
+1,065
| +1% | +$41K | 0.88% | 22 |
|
|
2018
Q2 | $3.15M | Buy |
91,519
+51
| +0.1% | +$1.74K | 0.78% | 31 |
|
|
2018
Q1 | $3.08M | Buy |
91,468
+2,370
| +3% | +$81.5K | 0.78% | 29 |
|
|
2017
Q4 | $3.06M | Sell |
89,098
-4,699
| -5% | -$160K | 0.79% | 29 |
|
|
2017
Q3 | $3.18M | Sell |
93,797
-2,340
| -2% | -$75.2K | 0.96% | 23 |
|
|
2017
Q2 | $3.06M | Buy |
96,137
+47
| +0% | +$1.48K | 0.96% | 27 |
|
|
2017
Q1 | $3.12M | Buy |
96,090
+2,947
| +3% | +$92.9K | 0.98% | 24 |
|
|
2016
Q4 | $2.87M | Buy |
93,143
+2,452
| +3% | +$74.9K | 0.95% | 25 |
|
|
2016
Q3 | $2.91M | Sell |
90,691
-634
| -0.7% | -$21.2K | 1.01% | 22 |
|
|
2016
Q2 | $3.05M | Buy |
91,325
+235
| +0.3% | +$7.5K | 1.09% | 21 |
|
|
2016
Q1 | $2.56M | Sell |
91,090
-5,192
| -5% | -$148K | 0.95% | 29 |
|
|
2015
Q4 | $2.95M | Buy |
96,282
+2,202
| +2% | +$69.3K | 1.1% | 19 |
|
|
2015
Q3 | $2.8M | Sell |
94,080
-1,430
| -1% | -$45.9K | 1.09% | 20 |
|
|
2015
Q2 | $3.04M | Sell |
95,510
-8,097
| -8% | -$264K | 1.06% | 19 |
|
|
2015
Q1 | $3.42M | Buy |
103,607
+19
| +0% | +$604 | 1.12% | 16 |
|
|
2014
Q4 | $3.06M | Sell |
103,588
-42
| -0% | -$1.2K | 1% | 22 |
|
|
2014
Q3 | $2.91M | Sell |
103,630
-3,142
| -3% | -$88.2K | 0.99% | 20 |
|
|
2014
Q2 | $3.01M | Buy |
106,772
+3,234
| +3% | +$92.2K | 0.97% | 19 |
|
|
2014
Q1 | $3.15M | Buy |
103,538
+21
| +0% | +$626 | 1.12% | 14 |
|
|
2013
Q4 | $3.01M | Buy |
103,517
+334
| +0.3% | +$9.72K | 1.08% | 14 |
|
|
2013
Q3 | $2.81M | Buy |
103,183
+19
| +0% | +$517 | 1.14% | 11 |
|
|
2013
Q2 | $2.74M | Buy |
+103,164
| New | +$2.85M | 1.05% | 10 |
|
Other funds holding PFE
Duncker Streett & Co's PFE Position: Q2 2026 in Review
Duncker Streett & Co increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $7.32K and bringing the position to 24,821 shares worth $598K. The position accounts for 0.1% of the portfolio, ranked #151.
Duncker Streett & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.88M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Duncker Streett & Co held 24,821 shares of Pfizer worth $598K as of Q2 2026.
- Duncker Streett & Co bought 280 Pfizer shares in Q2 2026, an estimated $7.32K.
- Pfizer made up 0.1% of Duncker Streett & Co's portfolio in Q2 2026, its #151 holding.
- Duncker Streett & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Duncker Streett & Co's Pfizer position peaked at $3.88M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.